Laiba Immad

Contributing Author

Recent Articles by Laiba Immad

Feb-02	Craig-Hallum Adjusts MiMedx Group, Inc. (MDXG) Outlook on CMS Coverage Guidance MDXG Insider Monkey
Feb-02	Black Diamond Therapeutics, Inc. (BDTX) Price Target Trimmed as Piper Updates Biotech Models and 2026 Catalyst Tracker BDTX Insider Monkey
Feb-02	Altimmune, Inc. (ALT) Gains Analyst Support Ahead of Phase 3 MASH Development ALT Insider Monkey
Feb-02	Piper Sandler See Label Expansion Potential for ImmunityBio, Inc. (IBRX)'s ANKTIVA Following QUILT Data IBRX Insider Monkey
Feb-02	Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARCT) Pipeline Assets ARCT Insider Monkey
Feb-02	H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)'s PKP2 Program LXEO Insider Monkey
Feb-02	Barclays Flags M&A Tailwinds and Pricing Relief as Upside Catalysts for 4D Molecular Therapeutics, Inc. (FDMT) FDMT Insider Monkey
Feb-02	H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO) KRRO Insider Monkey
Feb-02	Oppenheimer Notes Relay Therapeutics, Inc. (RLAY) Pipeline Strength in Mutant-Selective Inhibitors RLAY +6.40% Insider Monkey
Feb-02	TD Cowen Bullish on KalVista Pharmaceuticals, Inc. (KALV) Ahead of Q4 Results KALV Insider Monkey
Feb-02	H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss LEGN Insider Monkey
Feb-02	Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results ARDX Insider Monkey
Feb-02	Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX) CTMX +7.03% Insider Monkey
Feb-02	Baird Updates Intellia Therapeutics, Inc. (NTLA)'s Financial Model Following Nex-Z Clinical Hold Removal NTLA Insider Monkey
Feb-02	Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo's Support on Rett Syndrome Program Progress TSHA Insider Monkey
Feb-02	Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion KURA Insider Monkey
Feb-02	Goldman Sachs Notes VELA-2 Failure, Calls MoonLake Immunotherapeutics (MLTX) a High-Risk Play MLTX Insider Monkey
Feb-02	Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts NRIX Insider Monkey
Feb-02	Jefferies Downgrades Amicus Therapeutics, Inc. (FOLD) to Buy And Lowers Price Target Amid Takeover Developments FOLD Insider Monkey
Feb-02	Rosenblatt Highlights Tax Incentives and Sales Execution as Q4 Upside Drivers for Fortinet, Inc. (FTNT) FTNT Insider Monkey
Feb-02	Amphenol Corporation (APH) Gains Attention After Dual Price Target Raises APH Insider Monkey
Feb-02	William Blair Notes Rambus Inc. (RMBS) Positioned as Top DRAM Memory Supplier RMBS Insider Monkey
Feb-02	TD Cowen Expects Dynatrace, Inc. (DT) to Deliver Above-Expectations Results DT Insider Monkey
Feb-02	Nextpower Inc. (NXT) Posts "Beat and Raise" Quarter, Supports Higher Valuation NXT Insider Monkey
Feb-02	Needham Notes that Semiconductor Equipment Recovery Is Boosting Nova Ltd. (NVMI) NVMI Insider Monkey
Feb-02	Exodus Movement, Inc. (EXOD) Maintains Debt-Free Balance Sheet Amid Product Expansion EXOD -14.59% Insider Monkey
Feb-02	Oppenheimer Cites Strong Automotive and AI Demand Driving Monolithic Power Systems, Inc. (MPWR) Upside MPWR Insider Monkey
Feb-02	Phillip Securities Highlight 25%+ AI Software Growth Driving Palantir Technologies Inc. (PLTR) Upside PLTR Insider Monkey
Feb-02	BofA Cites Near-Term AV Uncertainties Affecting Uber Technologies, Inc. (UBER) Valuation UBER Insider Monkey
Jan-31	TD Cowen Downgrades SkyWater Technology, Inc. (SKYT) to Hold After IonQ Deal SKYT Insider Monkey
Jan-31	Morgan Stanley Turns Bearish on Safehold Inc. (SAFE) Citing Litigation and Fee Income Risks SAFE Insider Monkey
Jan-31	Keefe, Bruyette & Woods Lift Esquire Financial Holdings, Inc. (ESQ) Target After In-Line Core Performance ESQ Insider Monkey
Jan-31	UBS Sees Higher Spending Weighing on Afya Limited (AFYA)'s Near-Term Outlook AFYA Insider Monkey
Jan-31	High-Grade Silver and Gold Intercepts Boost Confidence in Avino Silver & Gold Mines Ltd. (ASM)'s Growth Plan ASM Insider Monkey
Jan-31	Northland Raises Innovative Aerosystems, Inc. (ISSC) Price Target to $24, Maintains Outperform on Retrofits Momentum ISSC Insider Monkey
Jan-31	BofA Notes Positive Interest in Novavax, Inc. (NVAX) Technology Despite Timing Concerns for Licensed Assets NVAX Insider Monkey
Jan-31	H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance CRMD Insider Monkey
Jan-31	DA Davidson Flag Elevated Non-Performing Assets as Key Risk for Old Second Bancorp, Inc. (OSBC) OSBC Insider Monkey
Jan-29	TD Cowen Calls Fortinet, Inc. (FTNT)'s Valuation Reasonable at Current Levels FTNT Insider Monkey
Jan-29	EQT Corporation (EQT) Viewed as a Core Holding Among Gas Producers EQT Insider Monkey
Jan-29	Analysts Favor Public Storage (PSA) Over Retail and Cold Storage REITs PSA Insider Monkey
Jan-29	Goldman Backs TransDigm Group Incorporated (TDG) After Aerospace Acquisitions TDG Insider Monkey
Jan-29	Morgan Stanley Viewed Simon Property Group, Inc. (SPG) as In-Line REIT Performer for 2026 SPG Insider Monkey
Jan-29	Susquehanna Sees AI Infrastructure Boost Supporting Analog Devices, Inc. (ADI) Outlook ADI Insider Monkey
Jan-29	UBS Maintains Buy on Venture Global, Inc. (NYSE:VG) And Cited Arbitration Resolution as Key Catalyst VG Insider Monkey
Jan-29	Analysts Split on Intuitive Surgical, Inc. (ISRG) Valuation Despite Strong Operating Momentum ISRG Insider Monkey
Jan-29	Freedom Capital Raised Prologis, Inc. (PLD)'s Target to $138, Cites Portfolio Strength Despite Downgrade PLD Insider Monkey
Jan-29	Goldman Sachs Project 2026 EPS of $17.50 for Royal Caribbean Cruises Ltd. (RCL) on Cost Discipline, New Ships RCL +18.65% Insider Monkey
Jan-29	Morgan Stanley Lowered Diamondback Energy, Inc. (FANG) Target to $171 And Maintained Overweight Rating FANG Insider Monkey
Jan-29	Canadian Pacific Kansas City Limited (CP) to Receive 70 Tier 4 Locomotives from Wabtec, 30 from Progress Rail This Year CP +5.66% Insider Monkey
Jan-29	Evercore ISI Highlights Dupixent and Eylea HD as Key Growth Drivers For Regeneron Pharmaceuticals, Inc. (REGN) REGN Insider Monkey
Jan-29	Morgan Stanley Notes Strong Q4 Operations for EOG Resources, Inc. (EOG) but Soft Cash Flow EOG Insider Monkey
Jan-29	Freedom Capital Boosts BlackRock, Inc. (BLK) Target Amid Strong Earnings Potential BLK Insider Monkey
Jan-29	Bernstein Bullish on ASML Holding N.V. (ASML) Amid Strong China-Related DUV Demand ASML Insider Monkey
Jan-29	Phillip Securities Cite Netflix, Inc. (NFLX)'s Market Leadership and Pricing Power for Long-Term Upside NFLX Insider Monkey
Jan-29	Morgan Stanley Flags GPU-as-a-Service Buildout as EPS Pressure Point for Oracle Corporation (ORCL) ORCL Insider Monkey
Jan-29	Rothschild Encourages Investors to Buy Meta Platforms, Inc. (META) on Any Post-Q4 Weakness META +10.40% Insider Monkey
Jan-29	Microsoft Corporation (MSFT)'s Fairwater AI Data Centers Drive Azure Growth Outlook MSFT -9.99% Insider Monkey
Jan-25	Goldman Sachs Turn Cautious on Similarweb Ltd. (SMWB) Amid Slowing Core Growth Metrics SMWB Insider Monkey
Jan-25	Analysts Maintain Cautious View on Sigma Lithium Corporation (SGML) Amid Operational Uncertainty SGML -9.70% Insider Monkey
Jan-25	Stephens Is Bullish on Guardian Pharmacy Services, Inc. (GRDN) After 2026 Forecast Update GRDN Insider Monkey
Jan-25	Analysts Highlight Improved Supply Conditions for Werner Enterprises, Inc. (WERN) WERN Insider Monkey
Jan-25	Analysts Turn Bullish on Ichor Holdings, Ltd. (ICHR) Amid Improving Semiconductor Demand ICHR Insider Monkey
Jan-25	H.C. Wainwright Is Bullish on Gold Royalty Corp. (GROY) Following Borborema Royalty Deal GROY Insider Monkey
Jan-25	Fastly, Inc. (FSLY) Gains Attention as AI Adoption Supports Infrastructure Software FSLY +5.27% Insider Monkey
Jan-25	Analysts Monitor Asset Recovery and Market Exposure at Sunstone Hotel Investors, Inc. (SHO) SHO Insider Monkey
Jan-25	Benchmark Sees Q1 Same-Store Sales Inflection for Dave & Buster's Entertainment, Inc. (PLAY) PLAY -7.50% Insider Monkey
Jan-25	Morgan Stanley Sees AI-Driven Demand Tailwinds for Amplitude, Inc. (AMPL) AMPL Insider Monkey
Jan-25	DiamondRock Hospitality Company (DRH) Exposure Skewed Toward Higher-End Leisure Demand DRH Insider Monkey
Jan-25	Analysts Question STAAR Surgical Company (STAA)'s Post-Merger Standalone Valuation STAA Insider Monkey
Jan-22	Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes LFST Insider Monkey
Jan-22	Veracyte, Inc. (VCYT) Sees Analyst Support as Guggenheim Reaffirms Buy Rating VCYT Insider Monkey
Jan-22	Kinsale Capital Group, Inc. (KNSL) Draws Mixed Analyst Views After New Coverage and Target Revision KNSL Insider Monkey
Jan-22	Palomar Holdings, Inc. (PLMR) Gains Analyst Support as JPMorgan and KBW Raise Targets PLMR Insider Monkey
Jan-22	Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves PGNY Insider Monkey
Jan-22	Analysts Expect Matador Resources Company (MTDR) to Navigate Lower Oil Prices Effectively MTDR Insider Monkey
Jan-22	Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves PTCT Insider Monkey
Jan-22	TD Cowen is Bullish on Alignment Healthcare, Inc. (ALHC) After Medicare Advantage Update ALHC Insider Monkey
Jan-22	Wells Fargo See Upside for Genius Sports Limited (GENI) on Expanding Media and Advertising Opportunity GENI Insider Monkey
Jan-22	TD Cowen is Bullish on Alignment Healthcare, Inc. (ALHC) After Medicare Advantage Update ALHC Insider Monkey
Jan-22	Piper Sandler Highlights Arrowhead Pharmaceuticals, Inc. (ARWR) Pipeline With Upcoming Phase III Hypertriglyceridemia Data ARWR Insider Monkey
Jan-22	e.l.f Beauty, Inc. (ELF) Maintains Analyst Attention With 2026 Growth Potential ELF Insider Monkey
Jan-22	Analysts See Mixed Outlook for Shift4 Payments, Inc. (FOUR) Amid Fintech Sector Risks FOUR Insider Monkey
Jan-22	Barclays Is Bullish on UiPath, Inc. (PATH) Amid Stable IT Spending Outlook PATH +6.69% Insider Monkey
Jan-22	Analysts Highlight Chord Energy Corporation (CHRD)'s Disciplined Approach to Capital and Shareholder Returns CHRD Insider Monkey
Jan-22	Wells Fargo Is Bullish on Inspire Medical Systems, Inc. (INSP) Despite Short-Term Reimbursement Concerns INSP -16.00% Insider Monkey
Jan-20	Genmab A/S (GMAB) Shares Gain Analyst Support as Deutsche Bank Sees Oncology Upside GMAB Insider Monkey
Jan-20	Novartis AG (NVS) Advances $23B U.S. Investment Plan With New RLT Logistics Hub NVS Insider Monkey
Jan-20	Exelixis, Inc. (EXEL) Sees Mixed Analyst Actions as Zanzalintinib Nears Commercial Launch EXEL Insider Monkey
Jan-20	Nuvation Bio Inc. (NUVB) Price Target Lowered as IBTROZI Sales Meet Expectations NUVB Insider Monkey
Jan-20	Merck & Co., Inc. (MRK) Poised for Breakout After Strategic M&A and Pipeline Expansion MRK Insider Monkey
Jan-20	Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside ILMN Insider Monkey
Jan-20	Analysts Turn More Bullish on Guardant Health, Inc. (GH) as 2026 Growth Catalysts Build GH Insider Monkey
Jan-20	AstraZeneca PLC (AZN) Gains After Successful Saphnelo Trial AZN Insider Monkey
Jan-20	Merck & Co., Inc. (MRK) Poised for Breakout After Strategic M&A and Pipeline Expansion MRK Insider Monkey
Jan-20	Analysts Remain Positive on BridgeBio Pharma, Inc. (BBIO) After Strong 2025 Results BBIO Insider Monkey
Jan-20	Scotiabank Notes Bristol-Myers Squibb Company (BMY) as Appealing Investment in 2026 BMY Insider Monkey
Jan-18	Monolithic Power Systems (MPWR) Emerges as High-Conviction AI Data Center Power Play MPWR Insider Monkey
Jan-18	Cardinal Health, Inc. (CAH) Shares Gain Favor as Citi Turns Bullish on Specialist Assets CAH Insider Monkey
Jan-18	Abbott Laboratories (ABT) Positioned to Benefit as Healthcare Sector Enters Recovery Phase ABT Insider Monkey

Laiba Immad

Recent Articles by Laiba Immad

Upgrade your FINVIZ experience